Dr. A. (Amir) Omidvari

Koopmann, B. D. M., Omidvari, A. H., Lansdorp-Vogelaar, I., Cahen, D. L., Bruno, M. J., & de Kok, I. M. C. M. (2023). The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies. International Journal of Cancer, 152(8), 1570-1580. https://doi.org/10.1002/ijc.34379

Mulder, S. T., Omidvari, A. H., Rueten-Budde, A. J., Huang, P. H., Kim, K. H., Bais, B., Rousian, M., Hai, R., Akgun, C., van Lennep, J. R., Willemsen, S., Rijnbeek, P. R., Tax, D. M., Reinders, M., Boersma, E., Rizopoulos, D., Visch, V., & Steegers-Theunissen, R. (2022). Dynamic Digital Twin: Diagnosis, Treatment, Prediction, and Prevention of Disease During the Life Course. Journal of Medical Internet Research, 24(9), Article e35675. https://doi.org/10.2196/35675

Rubenstein, J. H., Omidvari, A. H., Lauren, B. N., Hazelton, W. D., Lim, F., Tan, S. X., Kong, C. Y., Lee, M., Ali, A., Hur, C., Inadomi, J. M., Luebeck, G., & Lansdorp-Vogelaar, I. (2022). Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis. Gastroenterology, 163(1), 163-173. https://doi.org/10.1053/j.gastro.2022.03.037

Omidvari, A. H., Lansdorp-Vogelaar, I., de Koning, H. J., & Meester, R. G. S. (2021). Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration. PLoS ONE, 16(7 July), Article e0253893. https://doi.org/10.1371/journal.pone.0253893

Omidvari, A. H., Hazelton, W. D., Lauren, B. N., Naber, S. K., Lee, M., Ali, A., Seguin, C., Kong, C. Y., Richmond, E., Rubenstein, J. H., Luebeck, G. E., Inadomi, J. M., Hur, C., & Lansdorp-Vogelaar, I. (2021). The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis. Gastroenterology, 161(2), 487-494. https://doi.org/10.1053/j.gastro.2021.05.003

Peterse, E. F. P., Meester, R. G. S., De Jonge, L., Omidvari, A. H., Alarid-Escudero, F., Knudsen, A. B., Zauber, A. G., & Lansdorp-Vogelaar, I. (2021). Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests. Journal of the National Cancer Institute, 113(2), 154-161. https://doi.org/10.1093/jnci/djaa103

Rubenstein, JH., Noureldin, M., Tavakkoli, A., Hur, C., Omidvari, A., & Waljee, AK. (2020). Utilization of Surveillance Endoscopy for Barrett's Esophagus in Medicare Enrollees. Gastroenterology, 158, 773-775.e1. https://doi.org/10.1053/j.gastro.2019.10.022

Omidvari, A., Ali, A., Hazelton, WD., Kroep, S., Lee, M., Naber, S., Lauren, BN., Ostvar, S., Richmond, E., Kong, CY., Rubenstein, JH., Lansdorp - Vogelaar, I., Luebeck, G., Hur, C., & Inadomi, J. (2020). Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling. Clinical Gastroenterology and Hepatology, 18(9), 1961-1969. https://doi.org/10.1016/j.cgh.2019.11.058

Omidvari, A., Roumans, C., Naber, S., Kroep, S., Wijnhoven, B., van der Gaast, A., de Jonge, P. J., Spaander, M., & Lansdorp - Vogelaar, I. (2020). The Impact of the Policy-Practice Gap on Costs and Benefits of Barrett's Esophagus Management. American Journal of Gastroenterology, 115(7), 1026-1035. https://doi.org/10.14309/ajg.0000000000000578

Gini, A., Zauber, AG., Cenin, D., Omidvari, A., Hempstead, SE., Fink, AK., Lowenfels, AB., & Lansdorp - Vogelaar, I. (2018). Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer. Gastroenterology, 154(3), 556-+. https://doi.org/10.1053/j.gastro.2017.10.036

Heberle, CR., Omidvari, A., Ali, A., Kroep, S., Kong, CY., Inadomi, JM., Rubenstein, JH., Tramontano, AC., Dowling, EC., Hazelton, WD., Luebeck, EG., Lansdorp - Vogelaar, I., & Hur, C. (2017). Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device. Clinical Gastroenterology and Hepatology, 15(9), 1397-+. https://doi.org/10.1016/j.cgh.2017.02.017

Omidvari, A., Meester, R., & Lansdorp - Vogelaar, I. (2016). Cost effectiveness of surveillance for GI cancers. Best Practice & Research in Clinical Gastroenterology, 30(6), 879-891. https://doi.org/10.1016/j.bpg.2016.09.001

Omidvari, A. H., Lansdorp-Vogelaar, I., & Rubenstein, J. H. (2022). Reply. Gastroenterology, 162(1), 351-352. https://doi.org/10.1053/j.gastro.2021.09.056